Answers are grounded in this paper and cite their sources.
We have developed a rapid new in vivo method for screening experimental drugs for their activity against Mycobacterium tuberculosis by using the gamma interferon gene-disrupted (GKO) C57BL/6 mouse. Due to the rapid growth of the infection, statistical differences indicating positive efficacy of active compounds can be seen after only 8 days of treatment. To validate this model, several fluoroquinolones, including ciprofloxacin, levofloxacin, moxifloxacin, and gatifloxacin, were tested in parallel.
No takes yet. Share an insight, caveat, or question.
Lenaerts et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: